Bartolomeo AC, Morris H, Buccafusco JJ, Kille N, Rosenzweig-Lipson S, Husbands MG, Sabb AL, Abou-Gharbia M, Moyer JA, Boast CA (2000) <br />The preclinical pharmacological profile of WAY-132983, a potent M1 preferring agonist<br /><i>Journal of Pharmacology & Experimental Therapeutics</i> <b>292</b>: 584<br /><br />Sabb AL, Husbands MG, Tokolics J, Stein RP, Tasse RP, Boast CA, Moyer JA, Abou-Gharbia M (1999) <br />Discovery of a highly potent, functionally-selective muscarinic M1 agonist, WAY-132983 using rational drug design and receptor modelling<br /><i>Bioorganic & Medicinal Chemistry Lett</i> <b>9</b>: 1895<br /><br />Bartolomeo AC, Morris H, Boast CA (1997) <br />Arecoline via miniosmotic pump improves AF64A-impaired radial maze performance in rats: a possible model of Alzheimer's disease<br /><i>Neurobiol Learn Mem</i> <b>68</b>: 333<br /><br />Maurer SA, Storch FE, LaForge RR, Boast CA (1995) <br />Task difficulty determines the differential memory-impairing effects of EAA antagonists in gerbils<br /><i>Pharmacol Biochem Behav</i> <b>51</b>: 345<br /><br />Boast CA, Leventer S, Sabb A, Abelson M, Bender R, Giacomo D, Maurer S, McArthur S, Mehta O, Morris H, Moyer J, Storchet F (1991) <br />Biochemical and behavioral characterization of a novel cholinergic agonist, SR 95639<br /><i>Pharmacol Biochem Behav</i> <b>39</b>: 287<br /><br />Murphy DE, Boast CA (1985) <br />Searching for models of Alzheimer's disease: a comparison of four amnestic treatments in two behavioral tasks<br /><i>Annals of the New York Academy of Sciences</i> <b>444</b>: 450<br /><br />Boast CA, Bernard PS, Barbaz BS, Bergen KM (1983) <br />The neuropharmacology of various diazepam antagonists<br /><i>Neuropharmacology</i> <b>22</b>: 1511<br /><br />Fisher SK, Boast CA, Agranoff BW (1980) <br />The muscarinic stimulation of phospholipid labeling in hippocampus is independent of its cholinergic input<br /><i>Brain Research</i> <b>189</b>: 284<br /><br />